TDX/TDXFLX METHOTREXATE II 07A12-60

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2014-11-03 for TDX/TDXFLX METHOTREXATE II 07A12-60 manufactured by Abbott Laboratories.

Event Text Entries

[5002111] The customer reports that a serum blood sample taken 24 hours after the administration of methotrexate to a leukemia patient was divided into two aliquots (per customer's protocol) and tested with the tdx/tdxflx methotrexate ii assay on a tdx/flx analyzer. The first aliquot generated a result of 1. 11 umol/l and was reported from the lab. It was noted that no control samples were run for the assay on this day and that the buffer solution was replaced but was not flushed through the instrument before testing. The following day, the second aliquot was tested and generated a result of 273 umol/l. There was no volume left after these results were generated for any sample retesting. A second sample was obtained 48 hours post drug administration and generated results of 1. 70 and 1. 72 umol/l. Controls were run and were within specification on this day. The patient's oncologist questioned these results in comparison to the result of 1. 11 umol/l as he was expecting a drop in the drug concentration. The outcome of this issue is that there was a delay in administering calcium folinate by 12 hours to the patient after the methotrexate therapy. Urea nitrogen and creatinine levels taken did not indicate any kidney failure. There is no further impact to patient management reported.
Patient Sequence No: 1, Text Type: D, B5


[12485806] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[32505999] There were no returns available from the customer site for this evaluation. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. Accuracy testing was performed using retained reagents of lot 39298m500. Three different control levels were tested across three different analyzers. All results met specifications. The assay is performing as intended. The tdx/tdxflx methotrexate ii reagent assay package insert and the tdxflx system operations manual contain information to address the current customer issue. Based on the available information from the customer site and from the results of this evaluation, there is no evidence to reasonably suggest a product malfunction occurred as the incident was isolated to a discreet patient sample. Human error may have caused or contributed to the present event.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2014-00229
MDR Report Key4220324
Report Source01,05
Date Received2014-11-03
Date of Report2014-10-14
Date of Event2014-10-12
Date Mfgr Received2014-11-24
Device Manufacturer Date2014-04-01
Date Added to Maude2014-11-17
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 60064350
Manufacturer CountryUS
Manufacturer Postal Code60064 3500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTDX/TDXFLX METHOTREXATE II
Generic NameMETHOTREXATE
Product CodeLAO
Date Received2014-11-03
Catalog Number07A12-60
Lot Number39298M500
Device Expiration Date2015-07-29
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064350 US 60064 3500


Patients

Patient NumberTreatmentOutcomeDate
10 2014-11-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.